|Name||TWOCELLS COMPANY, LIMITED|
|Date established||April 23, 2003|
|Head office||Hiroshima Sangyou Bunka Center Bldg., 11F , 16-35 , Hijiyamahonmachi , Minami-ku , Hiroshima City|
|Capital||1,160 million yen (as of September 6, 2018)|
* external board members
Be natural. Don’t be either frolicked, bloated, mourn, sulked, or over-strained. We want to proceed our prompts slowly and steady; with best efforts and never-give-up mind against failures, and the appreciation for the encounters or cooperation we get from others. I think it‘ll be nice when we live naturally for what they are.
We once had many challenges to get over in front of us in order to proceed business, because the regenerative medicine was one of newest business fields. However, TWOCELLS had been established with many supports from the government, some well-reputed universities, etc. Therefore, we sense our mission to meet social expectations. （June 2015）
Very recently a number of pharmaceutical companies recognized cell therapy using stem cells as a promising new business target. Our company-TWOCELLS has special tools for mesenchymal stem cell (MSC) cultures such as chemically defined medium STK® series in addition to deep experiences on MSC cultures for more than 15 years. Taking this advantage, we will become a leading company in regenerative medicine, which undergoes the world-wide movement in the medical field. (September 2017)
I had strongly moved in response to the earnest request that want me to apply my experience to our business development and human resource development, from our president Tsuji. I will do my very best for the realization of the regenerative medicine with fellowship.
I have learned the real meaning of our three important terms after joining TWOCELLS; “Company” as “fellowship,” ”Value-Creating,” and “realization of regenerative medicine.” Then, I decided to pass down these terms to our stuff in the future, and to make regenerative medicine come true for patient waiting the treatment.
I have experienced the business in the automotive industry for 37years. Especially in last 10years I drove the business of the manufacturing company as CEO&CFO. The regeneration medicine is the new world to me. I, however, fully agree with the WILL of TWOCELLS and decide to join this team. I would contribute to accomplish the WILL utilizing my experience with the small fear and the big hope.
TWOCELLS is highly evaluated as a leading company for Tissue Engineering and Regenerative Medicine industry in Japan.I believe that the keys of success are management’s leadership, employee’s motivation and support from stakeholders.I am very proud of being a member of TWOCELLS as an outside director and will make my best to contribute its success.
Supported by many people, I have what I am now. I appreciate their support and I’d like to give them even a little more than what I was given by them, I eagerly hope so. I will not give up until I succeed in getting you to think profoundly it was nice selecting me as an outside director!
My favorite motto is “Brighten the World at Your Corner (Ichigu-wo-terasu)”.
I think that the investors estimate the TWOCELLS to be a company having the potential that only embodies regenerative medicine in this country.
I make the most of knowledge, experience, and the connection learned by the development of the high molecular hyaluronic acid in joint disease and think some contribution can be done for the success.
As a member of Board of Auditors, I hope our company supply regenerative technology to human health and life through the customer satisfaction、and that it may also contribute to the social activity in a viewpoint of the environmental issues on global warming for the corporate social responsibility.
From the viewpoint of maintaining firmly the ground on impartiality, necessary for an audit & supervisory board member, I would do my best for continuous self-study and want to meet social requirements and trust.
I will keep on doing my best as a company auditor in order that TWOCELLS can achieve success as a leader in the field of regenerative medicine, and have sufficient social credibility.